Assessment of angiogenic factors activity variation in the prediction of diabetic retinopathy progression after phacoemulsification

Cover Page

Cite item

Full Text

Abstract

Aim. To evaluate the variations of vascular endothelial growth factor and pigment epithelium-derived factor balance as a prognostic factor for diabetic retinopathy progression after phacoemulsification. Methods. The study analyzed 4 samples of tear fluid taken from 2 patients (2 examples per patient). Clinical and functional tests, such as visual acuity test, tonometry, refractometry, visual field test, biomicroscopy, direct ophthalmoscopy, immunoassay, optical coherence tomography, fluorescein angiography, were performed. Clinical and laboratory parameters of homeostasis, including tear concentration of vascular endothelial growth factor and pigment epithelium-derived factor, blood glycosylated hemoglobin level were examined before and after phacoemulsification. Dynamic ophthalmologic control of diabetic retinopathy clinical course was performed. Results. The concentration of pro-angiogenic vascular endothelial growth factor was noted in both cases after the surgery. Hence, in one patient its growth (375 pg/ml before surgery, 467 pg/ml after surgery) exceeded the changes of pigment epithelium-derived factor concentration (2.08 ng/ml before surgery, 1.6 ng/ml after surgery). The progression risk index was estimated as 1.245 for vascular endothelial growth factor and 0.77 for pigment epithelium-derived factor. In second patient, vascular endothelial growth factor also increased after surgery, although, it’s increase (from 335 pg/ml before surgery to 358 pg/ml after surgery) was similar to pigment epithelium-derived factor change (2.15 ng/ml before surgery, 2.02 ng/ml after surgery). The progression risk index in second patient was estimated as 1.07 for vascular endothelial growth factor and 0.94 for pigment epithelium-derived factor. These changes allowed to predict pro-angiogenic potential increase and progression of vascular damage from diabetic retinopathy, in first patient. The second patient had stable balance of pro- and anti-angiogenic factors, allowing to predict a favorable clinical course. Conclusion. The change in vascular endothelial growth factor and pigment epithelium-derived factor ratio over time may be used as a prognostic factor for diabetic retinopathy progression after phacoemulsification.

About the authors

K E Kuntysheva

Intersectional Science & Technology Complex «Eye Microsurgery» named after S.N. Fedorov, Moscow, Russia

Email: ksenia-ek@yandex.ru

References

  1. Кузнецов С.Л., Лихванцева В.Г., Арутюнян Е.В. и др. Изучение возможности регуляции ангиогенеза in vitro с помощью рекомбинантных фрагментов ингибиторов ангиогенеза эндостатина, тумстатина и PEDF // Вестн. РАМН. - 2013. - №4. - С. 65-69.
  2. Нероев В.В., Сарыгина О.И., Левкина О.А. Роль сосудистого эндотелиального фактора роста в патогенезе диабетической ретинопатии // Вестн. офтальмол. - 2009. - №2. - С. 58-60.
  3. Нестеров А.П. Диабетическая ретинопатия // РМЖ. - 2000. - Т. 8, №1. - С. 3-9.
  4. Ходжаев Н.С., Кунтышева К.Е., Виговский А.В. Способ прогнозирования прогрессирования диабетической ретинопатии в ранние сроки после выполнения ультразвуковой факоэмульсификации у больных с сахарным диабетом. Патент на изобретение №2478961. Бюлл. №10 от 10.04.2013.
  5. Amos A.F., McCarty D.J., Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010 // Diabet. Med. - 1997. - Vol. 14, suppl. 5. - Р. 1-85.
  6. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress // Endocr. Rev. - 2004. - Vol. 4. - Р. 581-611.
  7. The World Health Statistics report. - USA, 2012. - http://www.who.int/gho/publications/world_health_statistics/WHS2012_IndicatorCompendium.pdf (дата обращения: 01.02.2014).

© 2014 Kuntysheva K.E.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies